Keywords: فرموترول; Budesonide; Formoterol; Pharmacokinetic modeling; Asthma; AIC; akaike information criterion; ANOVA; analysis of variance; BE; bioequivalence; BIC; bayesian information criterion; BMI; body mass index; BSV%; percent between subject variability; BUD; budeso
مقالات ISI فرموترول (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فرموترول; Asthma control; Quality of life; Fluticasone; Formoterol; Fixed combination; Non-interventional;
Keywords: فرموترول; COPD; Aclidinium; Formoterol; Combination therapy; Clinical trial;
Keywords: فرموترول; Asthma; small airways; spirometry; impulse oscillometry; long-acting β-agonist; formoterol; salmeterol; ACQ; Asthma Control Questionnaire; AX; Reactance area under the curve; FEF25-75; Forced midexpiratory flow between 25% and 75% of forced vital capacit
Keywords: فرموترول; Asthma; Airflow limitation; Fixed airflow obstruction; Budesonide; Formoterol; Lung function; BUD/FM; Budesonide/formoterol; DPI; Dry-powder inhaler; FAO; Fixed airflow obstruction; FEV1/FVC; Ratio of forced expiratory volume in 1 second to forced vital c
Keywords: فرموترول; Asthma; Combination therapy; Fluticasone propionate; Formoterol; Single inhaler; Control
Keywords: فرموترول; LABA; Formoterol; Salmeterol; Chronic obstructive pulmonary disease; Asthma
Keywords: فرموترول; Beclometasone; Formoterol; Children; Adolescents; Adults; Asthma; AUC; area under the plasma drug concentration-time curve; BDP; beclometasone-dipropionate; B17MP; beclometasone-17-monopropionate; Cmax; maximum plasma concentration; FEV1; forced expirator
Keywords: فرموترول; budesonide; doxofylline; formoterol; montelukast, tiotropium;
Keywords: فرموترول; budesonide; doxofylline; formoterol; montelukast; tiotropium;
Keywords: فرموترول; asthma; combination therapy; formoterol; fluticasone; inhaled corticosteroid; long-acting β2-agonist;
Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort® (budesonide/formoterol) pressurized metered dose inhaler
Keywords: فرموترول; Spacer; Bioavailability; Budesonide; Formoterol; pMDI; Charcoal;
Targeting central β2 receptors ameliorates streptozotocin-induced neuroinflammation via inhibition of glycogen synthase kinase3 pathway in mice
Keywords: فرموترول; Aβ; amyloid β protein; AD; Alzheimer's disease; β2AR; β2 adrenoceptor; FAD; familial AD; F; formoterol; GSH; reduced glutathione; GSK-3; glycogen synthase kinase-3; GSK α and β; glycogen synthase kinase alpha and beta; H&E; hematoxylin &eosin; Iba1;
Review articleSymptom variability and control in COPD: Advantages of dual bronchodilation therapy
Keywords: فرموترول; Aclidinium; Formoterol; Chronic obstructive pulmonary disease; Lung function; Dual bronchodilator therapy; Symptom variability;
Anti-inflammatory effects of 1,8-cineole (eucalyptol) improve glucocorticoid effects in vitro: A novel approach of steroid-sparing add-on therapy for COPD and asthma?
Keywords: فرموترول; AQLQ; asthma quality of life questionnaire; BUD; budesonide; C; 1,8-cineole; COPD; chronic obstructive lung disease; COX-2; cyclooxygenase-2; ELISA; enzyme-linked immune-sorbent assays; FCS; fetal calf serum; F; formoterol; FEV1; forced expiratory volume
Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation
Keywords: فرموترول; Asthma; Cost-effectiveness; Fixed-dose combination inhalers; Formoterol; GINA; Real-life;
Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma
Keywords: فرموترول; Easyhaler; Asthma; Bronchodilation; Budesonide; Formoterol; Dry powder inhaler;
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD
Keywords: فرموترول; COPD; Formoterol; Budesonide; Spiromax; Turbuhaler
Review articleAchieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention
Keywords: فرموترول; Asthma; Beclometasone; Budesonide; Formoterol; ICS/LABA; Maintenance and reliever therapy; ACQ; Asthma Control Questionnaire; bd; twice-daily; CI; confidence interval; FACET; Formoterol and Corticosteroids Establishing Therapy; GINA; Global Initiative for
Calidad de vida del paciente asmático con beclometasona/formoterol. Análisis de coste-utilidad
Keywords: فرموترول; Asma; Calidad de vida; Farmacoeconomía; Análisis coste-utilidad; Beclometasona; FormoterolAsthma; Quality of life; Pharmacoeconomics; Cost-utility analysis; Beclomethasone; Formoterol
Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD
Keywords: فرموترول; Aclidinium; Formoterol; LAMA; Muscarinic antagonist; LABA; COPD;
Formoterol, a Highly β2-Selective Agonist, Induces Gender-Dimorphic Whole Body Leucine Metabolism in Humans
Keywords: فرموترول; β-ARs, β-adrenoceptors; BP, blood pressure; EE, energy expenditure; HR, heart rate; LBM, lean body mass; LIP, leucine incorporation into protein; Lox, leucine oxidation; LRa, leucine rate of appearance; KIC, ketoisocaproic acidBeta-agonist; Formoterol; Sk
Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside
Keywords: فرموترول; Aclidinium; Formoterol; Dual bronchodilation; COPD; Translation research;
Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI
Keywords: فرموترول; Breath-actuated; Asthma; Budesonide; Formoterol; Pressurized metered-dose; Inhaler;
Aclidinium bromide combined with formoterol inhibits remodeling parameters in lung epithelial cells through cAMP
Keywords: فرموترول; Aclidinium; Formoterol; COPD; Airway wall remodeling; Extracellular matrix; Epithelial-mesenchymal transition;
Simple quantitation of formoterol and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human urine by liquid chromatography-tandem mass spectrometry in doping control
Keywords: فرموترول; THC-COOH; Formoterol; Quantitative analysis; Liquid chromatography; Tandem mass spectrometryTHC-COOH, 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid; WADA, World Anti-doping Agency; GC–MS, gas chromatography–mass spectrometry; LC–MS/MS, liquid chromatog
Bronchodilator efficacy of tiotropium–formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD
Keywords: فرموترول; Tiotropium; Formoterol; COPD
Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A
Keywords: فرموترول; Long-acting β2-agonist; salmeterol; formoterol; salbutamol; asthma; allergy; rhinovirus; exacerbation; chemokine; dexamethasone; (S)-2-amino-4-(4-[heptyloxy]phenyl)-2-methylbutan-1-ol; protein phosphatase 2A; nuclear factor κB; AAD; Allergic airways dis
Formoterol, a Long-Acting β2 Adrenergic Agonist, Improves Cognitive Function and Promotes Dendritic Complexity in a Mouse Model of Down Syndrome
Keywords: فرموترول; Alzheimer’s disease; β2 adrenergic receptors; Down syndrome; formoterol; locus coeruleus; norepinephrine; Ts65Dn
Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics
Keywords: فرموترول; Asthma; Small airways; Extra fine inhalation drug delivery; Beclomethasone dipropionate; Formoterol;
An online field-amplification sample stacking method for the determination of β2-agonists in human urine by CE-ESI/MS
Keywords: فرموترول; Clenbuterol; Salbutamol; Terbutaline; Formoterol; CE-ESI-MS; FASS;
Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: A role for IκB
Keywords: فرموترول; β2-Adrenoceptor; Clenbuterol; Formoterol; NFκB; IκBα; Neuroinflammation; LPS; Brain;
Chronic treatment with indacaterol and airway response to salbutamol in stable COPD
Keywords: فرموترول; COPD; Indacaterol; Formoterol; Salbutamol; Tolerance
A simplified procedure for the analysis of formoterol in human urine by liquid chromatography–electrospray tandem mass spectrometry: Application to the characterization of the metabolic profile and stability of formoterol in urine
Keywords: فرموترول; Anti-doping analysis; Formoterol; LC–MS/MS; Urinary metabolites
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use
Keywords: فرموترول; COPD; Formoterol; Indacaterol; Salmeterol; Tiotropium
Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine
Keywords: فرموترول; Formoterol; β2-Agonist; Urine; Doping; LC-MS; Sport;
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion
Keywords: فرموترول; COPD; Natural Killer cells; Budesonide; Formoterol; Natural Killer cell receptors; IFN-γ
Relief of methacholine-induced bronchospasm with extrafine beclomethasone dipropionate/formoterol in comparison with salbutamol in asthma
Keywords: فرموترول; Formoterol; Salbutamol; Reliever; Methacholine; BronchoconstrictionBDP, Beclomethasone dipropionate; CI, Confidence interval; CFC, Chlorofluorocarbon; DPI, Dry powder inhaler; FEV1, Forced expiratory volume in the first second; FVC, Forced vital capacity;
Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation
Keywords: فرموترول; Steroid insensitivity; Severe asthma; Formoterol; Glucocorticoid receptor; Phosphatase; Phosphorylation; Receptor-indepedentcAMP, 3′-5′-cyclic adenosine monophosphate; ERK, extra-cellular signal-regulated kinase; GR, glucocorticoid receptor; JNK, c-Jun N-
Acute and short-term effect of an extra dose of formoterol in COPD patients
Keywords: فرموترول; COPD; Formoterol; Hyperinflation
AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD
Keywords: فرموترول; AZD9668; Budesonide; COPD; Formoterol; Neutrophil elastase
Efficacy of a fixed combination of ciclesonide and formoterol: The EXCITED-study
Keywords: فرموترول; Asthma; Ciclesonide; Formoterol; Fixed combination;
Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study
Keywords: فرموترول; COPD; Exacerbation; Budesonide; Formoterol; Randomized; Treatment
Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: AÂ randomized controlled trial
Keywords: فرموترول; Budesonide; formoterol; asthma; randomized controlled trial; safety; African American; AE; Adverse event; ATSM; Asthma Treatment Satisfaction Measure; ECG; Electrocardiogram; ICS; Inhaled corticosteroid; LABA; Long-acting β2-adrenergic agonist; pMDI; Pre
Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD
Keywords: فرموترول; Formoterol; Beclomethasone; Budesonide; COPD; Onset of action;
Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma
Keywords: فرموترول; Budesonide; Formoterol; Fluticasone; Salmeterol; Impulse oscillometry (IOS); Fractional exhaled nitric oxide (FeNO); Small airway
Rapid nongenomic actions of inhaled corticosteroids on long-acting β2-agonist transport in the airway
Keywords: فرموترول; Bronchial smooth muscle; Organic cation transporter; Inhaled corticosteroids; Nongenomic; Formoterol; AsthmaOCT, organic cation transporter; OCTN, organic cation/carnitine transporter; MPP+, N-methyl-4-phenylpyridinium
Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender
Keywords: فرموترول; Bronchodilators; Chronic obstructive pulmonary disease; FEV1; Formoterol; tiotropiumFOR, Formoterol; TIO, tiotropium; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroid; FEV1, forced expiratory volume in 1 second; FVC, forced vitals
Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD
Keywords: فرموترول; Mucus clearance; Formoterol; Tiotropium bromideCOPD, Chronic obstructive pulmonary disease; FEV1, Forced expiratory volume in 1 s; FVC, Forced vital capacity; Kr, Krypton; RV, Residual volume; Tc, Technetium
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
Keywords: فرموترول; Indacaterol; Formoterol; Salmeterol; Tiotropium; Dyspnoea; Health status